PACS Group (PACS) Competitors $9.78 +0.18 (+1.88%) Closing price 09/12/2025 03:59 PM EasternExtended Trading$9.91 +0.13 (+1.33%) As of 09/12/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PACS vs. RDNT, OPCH, SHC, BTSG, WGS, CON, SGRY, PRVA, VCYT, and HTFLShould you be buying PACS Group stock or one of its competitors? The main competitors of PACS Group include RadNet (RDNT), Option Care Health (OPCH), Sotera Health (SHC), BrightSpring Health Services (BTSG), GeneDx (WGS), Concentra Group Holdings Parent (CON), Surgery Partners (SGRY), Privia Health Group (PRVA), Veracyte (VCYT), and Heartflow (HTFL). These companies are all part of the "healthcare" industry. PACS Group vs. Its Competitors RadNet Option Care Health Sotera Health BrightSpring Health Services GeneDx Concentra Group Holdings Parent Surgery Partners Privia Health Group Veracyte Heartflow RadNet (NASDAQ:RDNT) and PACS Group (NYSE:PACS) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, risk, valuation, profitability and analyst recommendations. Which has more risk & volatility, RDNT or PACS? RadNet has a beta of 1.54, suggesting that its share price is 54% more volatile than the S&P 500. Comparatively, PACS Group has a beta of 0.89, suggesting that its share price is 11% less volatile than the S&P 500. Is RDNT or PACS more profitable? PACS Group has a net margin of 0.00% compared to RadNet's net margin of -0.78%. RadNet's return on equity of 2.41% beat PACS Group's return on equity.Company Net Margins Return on Equity Return on Assets RadNet-0.78% 2.41% 0.82% PACS Group N/A N/A N/A Which has better earnings & valuation, RDNT or PACS? PACS Group has higher revenue and earnings than RadNet. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRadNet$1.83B3.11$2.79M-$0.20-370.05PACS Group$3.56B0.42$112.87MN/AN/A Does the media refer more to RDNT or PACS? In the previous week, PACS Group had 6 more articles in the media than RadNet. MarketBeat recorded 19 mentions for PACS Group and 13 mentions for RadNet. RadNet's average media sentiment score of 1.13 beat PACS Group's score of 0.18 indicating that RadNet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 8 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PACS Group 5 Very Positive mention(s) 2 Positive mention(s) 8 Neutral mention(s) 3 Negative mention(s) 1 Very Negative mention(s) Neutral Do analysts rate RDNT or PACS? RadNet currently has a consensus target price of $76.80, indicating a potential upside of 3.77%. PACS Group has a consensus target price of $31.00, indicating a potential upside of 216.97%. Given PACS Group's higher probable upside, analysts clearly believe PACS Group is more favorable than RadNet.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score RadNet 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 3 Strong Buy rating(s) 3.25PACS Group 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 Do institutionals & insiders have more ownership in RDNT or PACS? 77.9% of RadNet shares are owned by institutional investors. 5.6% of RadNet shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. SummaryRadNet beats PACS Group on 9 of the 14 factors compared between the two stocks. Get PACS Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PACS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PACS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PACS vs. The Competition Export to ExcelMetricPACS GroupMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$1.46B$7.66B$5.84B$21.58BDividend YieldN/A2.76%5.68%3.49%P/E RatioN/A75.5875.4129.75Price / Sales0.4237.20515.9585.94Price / CashN/A24.1437.5625.00Price / BookN/A7.3512.154.58Net Income$112.87M$242.04M$3.29B$999.94M7 Day Performance-12.43%1.60%0.74%0.68%1 Month Performance-15.40%0.94%5.00%4.02%1 Year Performance-75.98%16.26%62.55%16.39% PACS Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PACSPACS Group3.054 of 5 stars$9.78+1.9%$31.00+217.0%-76.0%$1.46B$3.56B0.0032,433Trending NewsUpcoming EarningsHigh Trading VolumeRDNTRadNet3.4356 of 5 stars$71.99+0.8%$76.80+6.7%+9.2%$5.49B$1.83B-359.9311,021Positive NewsInsider TradeOPCHOption Care Health4.8735 of 5 stars$29.59+1.7%$35.75+20.8%-11.0%$4.72B$5.00B23.678,088News CoveragePositive NewsSHCSotera Health2.1725 of 5 stars$15.91+1.9%$16.00+0.6%-4.5%$4.44B$1.10B198.903,000Insider TradeHigh Trading VolumeBTSGBrightSpring Health Services2.464 of 5 stars$25.48+5.6%$25.67+0.7%+91.0%$4.27B$11.27B82.2035,000News CoverageAnalyst ForecastHigh Trading VolumeWGSGeneDx2.5612 of 5 stars$129.33-2.4%$101.63-21.4%+227.3%$3.81B$305.45M2,586.601,200Analyst ForecastCONConcentra Group Holdings Parent3.0351 of 5 stars$22.79-1.3%$27.50+20.7%-4.3%$2.96B$1.90B19.1511,250Positive NewsSGRYSurgery Partners3.1532 of 5 stars$22.08-1.9%$33.00+49.5%-29.5%$2.89B$3.11B-15.4415,000Positive NewsPRVAPrivia Health Group4.4345 of 5 stars$23.59+1.3%$28.58+21.2%+20.3%$2.86B$1.74B214.471,140Positive NewsVCYTVeracyte3.7551 of 5 stars$32.46+0.1%$40.90+26.0%-6.2%$2.55B$445.76M98.37790HTFLHeartflowN/A$34.50+11.0%$35.80+3.8%N/A$2.52BN/A0.00699Quiet Period ExpirationGap Up Related Companies and Tools Related Companies RDNT Alternatives OPCH Alternatives SHC Alternatives BTSG Alternatives WGS Alternatives CON Alternatives SGRY Alternatives PRVA Alternatives VCYT Alternatives HTFL Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:PACS) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredApple’s falling behindApple just posted record-breaking results, yet its stock barely moved — because in today’s market, investors o...Porter & Company | Sponsored6-Figure Target for BTC by 2025The U.S. just announced it's putting GDP data directly onto Bitcoin and Ethereum blockchains. Could this spa...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone thought he was insane…SpaceX just struck a $17 billion deal with EchoStar for radio frequencies, and tech analyst Jeff Brown says it...Brownstone Research | SponsoredWall Street Legend Issues Urgent AI Stock Warning'Hidden AI' is taking the U.S. stock market by storm.Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PACS Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PACS Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PACS Stock Alerts